What move does the options market price into Iovance Biotherapeutics's report?

Implied ±13.8%, either direction.

How often does Iovance Biotherapeutics move more than the options market prices?

5 of the last 8 reports moved at least as far as the implied move.

IOVANasdaqBiological Products, (No Diagnostic Substances)

Iovance Biotherapeutics, Inc. (IOVA) earnings date, market-implied expected move, and options open interest by expiry

8.01

−0.47 · −5.54%

post 7.98 −0.37%

Closed18:45 ET

Open7.97Volume21.0MMkt cap$3.6BEPS-0.70

Day7.86 – 8.1149%52-wk1.76 – 15.3746%

IOVA

Iovance Biotherapeutics, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±13.8%implied · straddle

8Q avg ±26.6%·×0.52·cheap

6.929.12

spot 8.02exp Nov 6ATM strike 8ATM straddle 1.30IV 195%

Nov 2 close

Expected move

Inputs

Next report

Nov 5

before open · in 2 days

est.Q3 FY26

Calendar

Next report

Last report

+43.09%

vs ±17.9% implied · ×2.40

shaded = implied · ▲▼ = realized

Aug 6 '26 · confirmed

Implied vs realized

Linked news

7hNVS · supplierBioArctic collaborator Novartis terminates agreement

News

Largest filed tie

13F top-10 QoQ

+19.21%

shares held · 10 largest managers

13F · Jun 30 '26126d lag

292 managers

Top fund weight

0.56%

IOVA weight · XBI

N-PORTJun 30 '26

4 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Iovance Biotherapeutics (IOVA) is expected to report on Nov 5 before open (estimated date).

Implied vs realized

8 reports

5 of 8≥ implied

avg implied: ±18.9%
avg realized: ±26.6%

Nov 7 '24Nov 7 '24confirmed±12.3%▼−13.80%×1.12

Feb 27 '25Feb 27 '25confirmed±23.2%▼−19.49%×0.84

May 8 '25May 8 '25confirmed±12.3%▼−44.79%×3.63

Aug 7 '25Aug 7 '25confirmed±23.0%▼−20.08%×0.87

Nov 6 '25Nov 6 '25confirmed±27.6%▲+27.62%×1.00

Q1 FY26Feb 24 '26confirmed±19.1%▲+30.80%×1.62

May 7 '26May 7 '26confirmed±16.0%▼−13.20%×0.83

Q2 FY26Aug 6 '26confirmed±17.9%▲+43.09%×2.40

quarterimplied−45%0+45%realized×

Q2 FY26±17.9%▲+43.09%×2.40

May '26±16.0%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 7 expiries · Oct 28 close

0.08OI · 7 expiries · Oct 28 closeP/C open interest · Nov 6 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

677+49%Nov 63d8,210+21%

1620%Nov 1310d0.37442+34%0.37

6,793+9%Nov 2017d0.5712,012+9%0.57

1370%Nov 2724d0.21659+64%0.21

11,697+2%Dec 1845d0.3434,6190%0.34

2 later expiries

83,9940%Jan 1573d0.64130,382+1%0.64

4,923+2%Mar 19136d0.28

ExpiryPutsCallsP/C

Nov 63d677+49%8,210+21%0.08

Nov 1310d1620%442+34%0.37

Nov 2017d6,793+9%12,012+9%0.57

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±13.8%

Funds 4

XBI±0.1%

IWM±0.0%

UWM±0.0%

VTI±0.0%

Dashed = straddleMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

as filedQ2 FY26

−47.64%as filednet margin · revenue +39.04% QoQ · +65.65% YoY

Revenue$99M+39.04%

Gross profit$56M56.10%+92.58%

Operating income−$52M−52.26%+35.95%

Pre-tax income−$49M+38.92%

Net income−$47M−47.64%+40.14%

Cost of revenue$44M+2.58%

Operating expenses$108M−2.14%

Tax−$1M−106.47%

Other income$3M+141.34%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 2 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 18:45 ET

Intraday

Event sensitivity

PPI ×1.18· ±4.9% vs ±4.2% · 10 releases

eventrelease day|move|up · n×base

PPIproducer prices±4.9%6 of 10×1.18

CPROFcorporate profits±4.9%6 of 12×1.16

CPIconsumer prices±4.0%3 of 10×0.95

FOMCrate decision±4.0%10 of 24×0.94

NFPjobs report±3.9%6 of 10×0.94

PCEpersonal income & outlays±3.6%7 of 19×0.85

GDPgross domestic product±3.4%10 of 19×0.80

Bar = avg |move| to ±5% · tick = ±4.2% avg day · ×base = |move| ÷ ±4.2% · min 6 releases

Earnings history

EPS -0.11 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 6 '26 · confirmed	-0.11	—
Q1 FY26	Feb 24 '26 · confirmed	-0.19	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod